Search

Displaying results 5351 - 5360 of 10000 in total
  1. Drug

    MPI-674

    go.drugbank.com/drugs/DB05749
    Experimental

    MPI-674 is an aromatase inhibitor (AI) with a well-established, multi-year chronic safety and tolerability profile. … AIs are a class of drugs that reduce the amount of estrogen circulating in the body by binding to and inhibiting the enzyme aromatase, which is responsible for converting certain hormones to estrogen.

  2. Drug

    Pavinetant

    go.drugbank.com/drugs/DB11692
    Investigational

    Pavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia.

  3. Drug

    Mitoglitazone

    go.drugbank.com/drugs/DB11721
    Investigational

    Mitoglitazone has been used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.

  4. Drug

    Pelitrexol

    go.drugbank.com/drugs/DB12757
    Investigational

    Pelitrexol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  5. Drug

    Timcodar

    go.drugbank.com/drugs/DB12761
    Investigational

    Timcodar has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  6. Drug

    Intoplicine

    go.drugbank.com/drugs/DB12868
    Investigational

    Intoplicine has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  7. Drug

    Falnidamol

    go.drugbank.com/drugs/DB12966
    Investigational

    Falnidamol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  8. Drug

    Miridesap

    go.drugbank.com/drugs/DB13087
    Investigational

    Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.

  9. Drug

    Fevipiprant

    go.drugbank.com/drugs/DB12011
    Investigational

    Fevipiprant has been used in trials studying the treatment of Asthma, Atopic Dermatitis, and Allergic Rhinitis.

  10. Drug

    Ozoralizumab

    go.drugbank.com/drugs/DB12014
    Investigational

    Ozoralizumab has been used in trials studying the treatment of Rheumatoid Arthritis and Active Rheumatoid Arthritis.